It’s been a crucial week for HCA Healthcare, Inc. (NYSE:HCA); here’s what analysts have to say.

October 2, 2018 - By Dolores Ford

HCA Healthcare, Inc. (NYSE:HCA) LogoInvestors sentiment increased to 1.14 in Q2 2018. Its up 0.18, from 0.96 in 2018Q1. It improved, as 37 investors sold HCA Healthcare, Inc. shares while 183 reduced holdings. 80 funds opened positions while 170 raised stakes. 239.10 million shares or 1.92% less from 243.77 million shares in 2018Q1 were reported.
Hbk Invests L P, a Texas-based fund reported 10,884 shares. Pictet Asset Mgmt stated it has 237,537 shares. 208,934 were accumulated by Aperio Group Limited Liability. Moreover, Loring Wolcott Coolidge Fiduciary Advsr Llp Ma has 0% invested in HCA Healthcare, Inc. (NYSE:HCA). Oppenheimer Inc holds 28,199 shares or 0.08% of its portfolio. Tocqueville Asset Management L P holds 13,033 shares. Moreover, Point72 Asset Mngmt L P has 0.06% invested in HCA Healthcare, Inc. (NYSE:HCA). Pinnacle Fincl Inc, a Tennessee-based fund reported 90,494 shares. Polar Llp accumulated 610,000 shares. Foster & Motley Incorporated owns 3,417 shares. Tower Research Lc (Trc) reported 0.06% of its portfolio in HCA Healthcare, Inc. (NYSE:HCA). Partner Fund Management Ltd Partnership has 522,345 shares for 0.84% of their portfolio. Comml Bank Of Ny Mellon has 0.06% invested in HCA Healthcare, Inc. (NYSE:HCA) for 2.08 million shares. National Pension Serv accumulated 312,320 shares or 0.15% of the stock. Origin Asset Limited Liability Partnership accumulated 92,800 shares.

Since May 14, 2018, it had 0 buys, and 14 insider sales for $19.61 million activity. On Monday, May 14 Englebright Jane D. sold $596,580 worth of HCA Healthcare, Inc. (NYSE:HCA) or 5,822 shares. Another trade for 1,689 shares valued at $190,063 was made by Torres Kathryn A. on Monday, July 23. Shares for $10.16 million were sold by Perlin Jonathan B. $665,487 worth of stock was sold by Cuffe Michael S. on Thursday, July 26. 6,419 shares were sold by Wyatt Christopher F., worth $810,271. The insider Morrow J William sold 4,977 shares worth $604,795.

HCA Healthcare, Inc. (NYSE:HCA) Ratings Coverage

Among 7 analysts covering HCA Holdings (NYSE:HCA), 5 have Buy rating, 2 Sell and 0 Hold. Therefore 71% are positive. HCA Holdings had 10 analyst reports since April 25, 2018 according to SRatingsIntel. The stock has “Outperform” rating by Credit Suisse on Friday, July 27. BMO Capital Markets maintained it with “Outperform” rating and $155 target in Wednesday, September 5 report. Leerink Swann maintained it with “Outperform” rating and $150 target in Tuesday, September 4 report. Morgan Stanley maintained HCA Healthcare, Inc. (NYSE:HCA) rating on Friday, July 13. Morgan Stanley has “Underweight” rating and $98 target. The rating was maintained by Bank of America with “Underperform” on Tuesday, September 18. The firm has “Underweight” rating given on Thursday, August 16 by Morgan Stanley. As per Wednesday, September 5, the company rating was maintained by Morgan Stanley. The firm has “Buy” rating by Cantor Fitzgerald given on Wednesday, April 25. The stock of HCA Healthcare, Inc. (NYSE:HCA) earned “Buy” rating by Cantor Fitzgerald on Tuesday, May 1. Below is a list of HCA Healthcare, Inc. (NYSE:HCA) latest ratings and price target changes.

18/09/2018 Broker: Bank of America Old Rating: Underperform New Rating: Underperform Old Target: $125 New Target: $135 Maintain
05/09/2018 Broker: BMO Capital Markets Old Rating: Outperform New Rating: Outperform Old Target: $145 New Target: $155 Maintain
05/09/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Underweight Old Target: $115 New Target: $124 Maintain
04/09/2018 Broker: Leerink Swann Old Rating: Outperform New Rating: Outperform Old Target: $140 New Target: $150 Maintain
16/08/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Underweight Old Target: $105 New Target: $115 Maintain
14/08/2018 Broker: Barclays Capital Rating: Overweight New Target: $150 Initiates Coverage On
27/07/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $122 New Target: $143 Maintain
13/07/2018 Broker: Morgan Stanley Old Rating: Underweight New Rating: Underweight Old Target: $91 New Target: $98 Maintain
01/05/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $115.0000 Maintain
25/04/2018 Broker: Cantor Fitzgerald Rating: Buy New Target: $115.0000 Maintain

The stock decreased 0.58% or $0.82 during the last trading session, reaching $139.48. About 353,121 shares traded. HCA Healthcare, Inc. (NYSE:HCA) has risen 66.96% since October 2, 2017 and is uptrending. It has outperformed by 51.34% the S&P500.

HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States and England. The company has market cap of $48.27 billion. The firm operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services. It has a 17.62 P/E ratio. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling.

More recent HCA Healthcare, Inc. (NYSE:HCA) news were published by: Bizjournals.com which released: “Here’s how much money Milton Johnson will make as an HCA adviser” on September 13, 2018. Also Bizjournals.com published the news titled: “Memorial Hermann Health System to merge with major Dallas system” on October 01, 2018. Bizjournals.com‘s news article titled: “HCA’s Milton Johnson to retire, next CEO revealed” with publication date: September 10, 2018 was also an interesting one.

HCA Healthcare, Inc. (NYSE:HCA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>